Compile Data Set for Download or QSAR
Report error Found 165 Enz. Inhib. hit(s) with all data for entry = 2999
TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316174(US9617225, Example 2 | N-(3-((1H-benzo[d]imidazol-...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316176(US9617225, Example 4 | N-(2-methoxy-5-(6-(2-methox...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316179(US9617225, Example 7 | 2-chloro-5-(6-(2-methoxyphe...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316181(US9617225, Example 9 | N-(2-methoxy-5-(6-(2-methox...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316182(US9617225, Example 10 | (2-methoxy-5-(6-(2-methoxy...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316188(US9617225, Example 16 | N-(3-((1H-benzo[d]imidazol...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316189(US9617225, Example 17 | (5-(6-(2-methoxyphenyl)pyr...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316202(US9617225, Example 30 | methyl 2-methoxy-5-(6-(2-m...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316203(US9617225, Example 31 | N-(3-((1H-benzo[d]imidazol...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316204(US9617225, Example 32 | 2-methoxy-5-(6-(2- methoxy...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316205(US9617225, Example 33 | 2-methoxy-5-(6-(2-methoxyp...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316207(US9617225, Example 35 | N-(3-((dimethylamino)methy...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316209(US9617225, Example 37 | N-(4-methoxy-3-((methylami...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316210(US9617225, Example 38 | 5-(6-(2-methoxyphenyl)pyri...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316211(US9617225, Example 39 | N-(3-((1H-benzo[d]imidazol...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316212(US9617225, Example 40 | N-(3-((1H-benzo[d]imidazol...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316217(US9617225, Example 45 | 2-methoxy-5-(6-(2- methoxy...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316227(US9617225, Example 55 | N-{2-Methoxy-5-[6-(2-metho...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316285(2-Dimethylamino-5-[6-(4-fluoro-2-methoxy-phenyl)-p...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316288([6-(2-Methoxy-phenyl)-pyrimidin-4-yl]-[4-methoxy-3...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316293(2-Methoxy-4-[6-(2-methoxy-phenyl)-pyrimidin-4-ylam...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316301(5-[6-(2-Ethoxy-phenyl)-pyrimidin-4- ylamino]-2-met...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316302(5-[6-(2-Ethoxy-4-fluoro-phenyl)- pyrimidin-4-ylami...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM7585(2,6,9-Trisubstituted purine deriv. 27 | CHEMBL5238...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM5655(2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydr...)
Affinity DataIC50: 100nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316172(US9617225, Example 1 | N-(3-((benzylamino)methyl)-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316175(US9617225, Example 3 | 2-(2-methoxy-5-(6-(2-methox...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316177(US9617225, Example 5 | N1-(6-(2-methoxyphenyl)pyri...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316178(US9617225, Example 6 | (2-chloro-5-(6-(2-methoxyph...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316180(US9617225, Example 8 | N-(4-methoxy-3-(2-morpholin...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316183(US9617225, Example 11 | N-(4-methoxy-3-nitrophenyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316184(US9617225, Example 12 | 4-(6-(2-methoxyphenyl)pyri...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316185(US9617225, Example 13 | (2-methoxy-5-(6-(2-methoxy...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316186(US9617225, Example 14 | ethyl 2-chloro-5-(6-(2-met...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316187(US9617225, Example 15 | (2-chloro-5-(6-(2-methoxyp...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316190(US9617225, Example 18 | ethyl 5-(6-(2-methoxypheny...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316191(US9617225, Example 19 | (5-(6-(2-methoxyphenyl)pyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316193(US9617225, Example 21 | methyl 2-hydroxy-5-(6-(2-m...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316194(US9617225, Example 22 | N-(3-fluoro-4-methoxypheny...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316195(US9617225, Example 23 | N-benzyl-2-methoxy-5-(6-(2...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316196(US9617225, Example 24 | (2-methoxy-5-(6-(2-methoxy...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316197(US9617225, Example 25 | 2-methoxy-5-(6-(2-methoxyp...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316200(US9617225, Example 28 | 2-methoxy-5-(6-(2-methoxyp...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316201(US9617225, Example 29 | 2-methoxy-5-(6-(2-methoxyp...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316213(US9617225, Example 41 | 4-methoxy-N1-(6-(2- methox...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316214(US9617225, Example 42 | 2-((1H-benzo[d]imidazol-1-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316215(US9617225, Example 43 | N-(3-(aminomethyl)-4- meth...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316216(US9617225, Example 44 | 2-chloro-5-(6-(2-methoxyph...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316218(US9617225, Example 46 | 2-Methoxy-5-[6-(2-methoxy-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetCyclin-T1/Cyclin-dependent kinase 9(Human)
Virostatics

US Patent
LigandPNGBDBM316219(US9617225, Example 47 | 2-Methoxy-5-[6-(2-methoxy-...)
Affinity DataIC50: 1.00E+3nMAssay Description:The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 165 total ) | Next | Last >>
Jump to: